Home > Healthcare & Medical Devices > Antiviral Drugs Market > Table of Contents

Antiviral Drugs Market Size By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors), By Indication (Influenza, HIV AIDS, Hepatitis, Herpes Simplex Virus [HSV], Coronavirus Infection), By Type (Branded, Generic), By Age Group (Pediatric, Adult, Geriatric), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022 – 2028

  • Report ID: GMI4968
  • Published Date: Mar 2022
  • Report Format: PDF

Report Content

Chapter 1   Methodology

1.1    Market definitions

1.2    Base estimates and working

1.2.1    North America

1.2.2    Europe

1.2.3    Asia Pacific

1.2.4    Latin America

1.2.5    MEA

1.3    Forecast calculations

1.4    Data validation

1.5    Data sources

1.5.1    Secondary

1.5.1.1    Paid sources

1.5.1.2    Unpaid sources

1.5.2    Primary

Chapter 2   Executive Summary

2.1    Antiviral drugs market industry 3600 synopsis

2.1.1    Business trends

2.1.2    Drug class trends

2.1.3    Indication trends

2.1.4    Type trends

2.1.5    Age group trends

2.1.6    Regional trends

Chapter 3   Antiviral Drugs Market Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2017 - 2028 (USD Million)

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Rising prevalence of viral infections including COVID-19

3.3.1.2    Increasing number of product launches for HIV treatment

3.3.1.3    High investment in R&D activities and presence of pipeline products

3.3.1.4    Increasing geriatric population

3.3.2    Industry pitfalls & challenges

3.3.2.1    Presence of generics

3.3.2.2    Rising awareness about preventive drugs treatment

3.3.2.3    Drug resistance

3.4    Growth potential analysis

3.4.1    By drug class

3.4.2    By indication

3.4.3    By type

3.4.4    By age group

3.5    COVID-19 impact analysis

3.6    Regulatory landscape

3.7    Porter's analysis

3.8    Competitive landscape, 2021

3.9    PESTEL analysis

Chapter 4   Antiviral Drugs Market, By Drug Class

4.1    Key segment trends

4.2    DNA polymerase inhibitors

4.2.1    Market size, by region, 2017 - 2028 (USD Million)

4.3    Reverse transcript inhibitors

4.3.1    Market size, by region, 2017 - 2028 (USD Million)

4.4    Protease inhibitors

4.4.1    Market size, by region, 2017 - 2028 (USD Million)

4.5    Neuraminidase inhibitors

4.5.1    Market size, by region, 2017 - 2028 (USD Million)

4.6    Others

4.6.1    Market size, by region, 2017 - 2028 (USD Million)

Chapter 5   Antiviral Drugs Market, By Indication

5.1    Key segment trends

5.2    Influenza

5.2.1    Market size, by region, 2017 - 2028 (USD Million)

5.3    HIV AIDS

5.3.1    Market size, by region, 2017 - 2028 (USD Million)

5.4    Hepatitis

5.4.1    Market size, by region, 2017 - 2028 (USD Million)

5.5    Herpes simplex virus (HSV)

5.5.1    Market size, by region, 2017 - 2028 (USD Million)

5.6    Coronavirus infection

5.6.1    Market size, by region, 2017 - 2028 (USD Million)

5.7    Others

5.7.1    Market size, by region, 2017 - 2028 (USD Million)

Chapter 6   Antiviral Drugs Market, By Type

6.1    Key segment trends

6.2    Branded

6.2.1    Market size, by region, 2017 - 2028 (USD Million)

6.3    Generic

6.3.1    Market size, by region, 2017 - 2028 (USD Million)

Chapter 7   Antiviral Drugs Market, By Age Group

7.1    Key segment trends

7.2    Adult

7.2.1    Market size, by region, 2017 - 2028 (USD Million)

7.3    Pediatric

7.3.1    Market size, by region, 2017 - 2028 (USD Million)

7.4    Geriatric

7.4.1    Market size, by region, 2017 - 2028 (USD Million)

Chapter 8   Antiviral Drugs Market, By Region

8.1    Key regional trends

8.2    North America

8.2.1    Market size, by country, 2017 - 2028 (USD Million)

8.2.2    Market size, by drug class, 2017 - 2028 (USD Million)

8.2.3    Market size, by indication, 2017 - 2028 (USD Million)

8.2.4    Market size, by type, 2017 - 2028 (USD Million)

8.2.5    Market size, by age group, 2017 - 2028 (USD Million)

8.2.6    U.S.

8.2.6.1    Market size, by drug class, 2017 - 2028 (USD Million)

8.2.6.2    Market size, by indication, 2017 - 2028 (USD Million)

8.2.6.3    Market size, by type, 2017 - 2028 (USD Million)

8.2.6.4    Market size, by age group, 2017 - 2028 (USD Million)

8.2.7    Canada

8.2.7.1    Market size, by drug class, 2017 - 2028 (USD Million)

8.2.7.2    Market size, by indication, 2017 - 2028 (USD Million)

8.2.7.3    Market size, by type, 2017 - 2028 (USD Million)

8.2.7.4    Market size, by age group, 2017 - 2028 (USD Million)

8.3    Europe

8.3.1    Market size, by country, 2017 - 2028 (USD Million)

8.3.2    Market size, by drug class, 2017 - 2028 (USD Million)

8.3.3    Market size, by indication, 2017 - 2028 (USD Million)

8.3.4    Market size, by type, 2017 - 2028 (USD Million)

8.3.5    Market size, by age group, 2017 - 2028 (USD Million)

8.3.6    Germany

8.3.6.1    Market size, by drug class, 2017 - 2028 (USD Million)

8.3.6.2    Market size, by indication, 2017 - 2028 (USD Million)

8.3.6.3    Market size, by type, 2017 - 2028 (USD Million)

8.3.6.4    Market size, by age group, 2017 - 2028 (USD Million)

8.3.7    UK

8.3.7.1    Market size, by drug class, 2017 - 2028 (USD Million)

8.3.7.2    Market size, by indication, 2017 - 2028 (USD Million)

8.3.7.3    Market size, by type, 2017 - 2028 (USD Million)

8.3.7.4    Market size, by age group, 2017 - 2028 (USD Million)

8.3.8    France

8.3.8.1    Market size, by drug class, 2017 - 2028 (USD Million)

8.3.8.2    Market size, by indication, 2017 - 2028 (USD Million)

8.3.8.3    Market size, by type, 2017 - 2028 (USD Million)

8.3.8.4    Market size, by age group, 2017 - 2028 (USD Million)

8.3.9    Spain

8.3.9.1    Market size, by drug class, 2017 - 2028 (USD Million)

8.3.9.2    Market size, by indication, 2017 - 2028 (USD Million)

8.3.9.3    Market size, by type, 2017 - 2028 (USD Million)

8.3.9.4    Market size, by age group, 2017 - 2028 (USD Million)

8.3.10    Italy

8.3.10.1    Market size, by drug class, 2017 - 2028 (USD Million)

8.3.10.2    Market size, by indication, 2017 - 2028 (USD Million)

8.3.10.3    Market size, by type, 2017 - 2028 (USD Million)

8.3.10.4    Market size, by age group, 2017 - 2028 (USD Million)

8.3.11    Russia

8.3.11.1    Market size, by drug class, 2017 - 2028 (USD Million)

8.3.11.2    Market size, by indication, 2017 - 2028 (USD Million)

8.3.11.3    Market size, by type, 2017 - 2028 (USD Million)

8.3.11.4    Market size, by age group, 2017 - 2028 (USD Million)

8.3.12    Poland

8.3.12.1    Market size, by drug class, 2017 - 2028 (USD Million)

8.3.12.2    Market size, by indication, 2017 - 2028 (USD Million)

8.3.12.3    Market size, by type, 2017 - 2028 (USD Million)

8.3.12.4    Market size, by age group, 2017 - 2028 (USD Million)

8.3.13    Switzerland

8.3.13.1    Market size, by drug class, 2017 - 2028 (USD Million)

8.3.13.2    Market size, by indication, 2017 - 2028 (USD Million)

8.3.13.3    Market size, by type, 2017 - 2028 (USD Million)

8.3.13.4    Market size, by age group, 2017 - 2028 (USD Million)

8.3.14    The Netherlands

8.3.14.1    Market size, by drug class, 2017 - 2028 (USD Million)

8.3.14.2    Market size, by indication, 2017 - 2028 (USD Million)

8.3.14.3    Market size, by type, 2017 - 2028 (USD Million)

8.3.14.4    Market size, by age group, 2017 - 2028 (USD Million)

8.3.15    Sweden

8.3.15.1    Market size, by drug class, 2017 - 2028 (USD Million)

8.3.15.2    Market size, by indication, 2017 - 2028 (USD Million)

8.3.15.3    Market size, by type, 2017 - 2028 (USD Million)

8.3.15.4    Market size, by age group, 2017 - 2028 (USD Million)

8.4    Asia Pacific

8.4.1    Market size, by country, 2017 - 2028 (USD Million)

8.4.2    Market size, by drug class, 2017 - 2028 (USD Million)

8.4.3    Market size, by indication, 2017 - 2028 (USD Million)

8.4.4    Market size, by type, 2017 - 2028 (USD Million)

8.4.5    Market size, by age group, 2017 - 2028 (USD Million)

8.4.6    Japan

8.4.6.1    Market size, by drug class, 2017 - 2028 (USD Million)

8.4.6.2    Market size, by indication, 2017 - 2028 (USD Million)

8.4.6.3    Market size, by type, 2017 - 2028 (USD Million)

8.4.6.4    Market size, by age group, 2017 - 2028 (USD Million)

8.4.7    China

8.4.7.1    Market size, by drug class, 2017 - 2028 (USD Million)

8.4.7.2    Market size, by indication, 2017 - 2028 (USD Million)

8.4.7.3    Market size, by type, 2017 - 2028 (USD Million)

8.4.7.4    Market size, by age group, 2017 - 2028 (USD Million)

8.4.8    India

8.4.8.1    Market size, by drug class, 2017 - 2028 (USD Million)

8.4.8.2    Market size, by indication, 2017 - 2028 (USD Million)

8.4.8.3    Market size, by type, 2017 - 2028 (USD Million)

8.4.8.4    Market size, by age group, 2017 - 2028 (USD Million)

8.4.9    Australia

8.4.9.1    Market size, by drug class, 2017 - 2028 (USD Million)

8.4.9.2    Market size, by indication, 2017 - 2028 (USD Million)

8.4.9.3    Market size, by type, 2017 - 2028 (USD Million)

8.4.9.4    Market size, by age group, 2017 - 2028 (USD Million)

8.4.10    South Korea

8.4.10.1    Market size, by drug class, 2017 - 2028 (USD Million)

8.4.10.2    Market size, by indication, 2017 - 2028 (USD Million)

8.4.10.3    Market size, by type, 2017 - 2028 (USD Million)

8.4.10.4    Market size, by age group, 2017 - 2028 (USD Million)

8.4.11    Singapore

8.4.11.1    Market size, by drug class, 2017 - 2028 (USD Million)

8.4.11.2    Market size, by indication, 2017 - 2028 (USD Million)

8.4.11.3    Market size, by type, 2017 - 2028 (USD Million)

8.4.11.4    Market size, by age group, 2017 - 2028 (USD Million)

8.4.12    Indonesia

8.4.12.1    Market size, by drug class, 2017 - 2028 (USD Million)

8.4.12.2    Market size, by indication, 2017 - 2028 (USD Million)

8.4.12.3    Market size, by type, 2017 - 2028 (USD Million)

8.4.12.4    Market size, by age group, 2017 - 2028 (USD Million)

8.4.13    Thailand

8.4.13.1    Market size, by drug class, 2017 - 2028 (USD Million)

8.4.13.2    Market size, by indication, 2017 - 2028 (USD Million)

8.4.13.3    Market size, by type, 2017 - 2028 (USD Million)

8.4.13.4    Market size, by age group, 2017 - 2028 (USD Million)

8.4.14    Malaysia

8.4.14.1    Market size, by drug class, 2017 - 2028 (USD Million)

8.4.14.2    Market size, by indication, 2017 - 2028 (USD Million)

8.4.14.3    Market size, by type, 2017 - 2028 (USD Million)

8.4.14.4    Market size, by age group, 2017 - 2028 (USD Million)

8.4.15    Philippines

8.4.15.1    Market size, by drug class, 2017 - 2028 (USD Million)

8.4.15.2    Market size, by indication, 2017 - 2028 (USD Million)

8.4.15.3    Market size, by type, 2017 - 2028 (USD Million)

8.4.15.4    Market size, by age group, 2017 - 2028 (USD Million)

8.5    Latin America

8.5.1    Market size, by country, 2017 - 2028 (USD Million)

8.5.2    Market size, by drug class, 2017 - 2028 (USD Million)

8.5.3    Market size, by indication, 2017 - 2028 (USD Million)

8.5.4    Market size, by type, 2017 - 2028 (USD Million)

8.5.5    Market size, by age group, 2017 - 2028 (USD Million)

8.5.6    Brazil

8.5.6.1    Market size, by drug class, 2017 - 2028 (USD Million)

8.5.6.2    Market size, by indication, 2017 - 2028 (USD Million)

8.5.6.3    Market size, by type, 2017 - 2028 (USD Million)

8.5.6.4    Market size, by age group, 2017 - 2028 (USD Million)

8.5.7    Mexico

8.5.7.1    Market size, by drug class, 2017 - 2028 (USD Million)

8.5.7.2    Market size, by indication, 2017 - 2028 (USD Million)

8.5.7.3    Market size, by type, 2017 - 2028 (USD Million)

8.5.7.4    Market size, by age group, 2017 - 2028 (USD Million)

8.5.8    Argentina

8.5.8.1    Market size, by drug class, 2017 - 2028 (USD Million)

8.5.8.2    Market size, by indication, 2017 - 2028 (USD Million)

8.5.8.3    Market size, by type, 2017 - 2028 (USD Million)

8.5.8.4    Market size, by age group, 2017 - 2028 (USD Million)

8.6    Middle East & Africa

8.6.1    Market size, by country, 2017 - 2028 (USD Million)

8.6.2    Market size, by drug class, 2017 - 2028 (USD Million)

8.6.3    Market size, by indication, 2017 - 2028 (USD Million)

8.6.4    Market size, by type, 2017 - 2028 (USD Million)

8.6.5    Market size, by age group, 2017 - 2028 (USD Million)

8.6.6    Saudi Arabia

8.6.6.1    Market size, by drug class, 2017 - 2028 (USD Million)

8.6.6.2    Market size, by indication, 2017 - 2028 (USD Million)

8.6.6.3    Market size, by type, 2017 - 2028 (USD Million)

8.6.6.4    Market size, by age group, 2017 - 2028 (USD Million)

8.6.7    South Africa

8.6.7.1    Market size, by drug class, 2017 - 2028 (USD Million)

8.6.7.2    Market size, by indication, 2017 - 2028 (USD Million)

8.6.7.3    Market size, by type, 2017 - 2028 (USD Million)

8.6.7.4    Market size, by age group, 2017 - 2028 (USD Million)

8.6.8    UAE

8.6.8.1    Market size, by drug class, 2017 - 2028 (USD Million)

8.6.8.2    Market size, by indication, 2017 - 2028 (USD Million)

8.6.8.3    Market size, by type, 2017 - 2028 (USD Million)

8.6.8.4    Market size, by age group, 2017 - 2028 (USD Million)

Chapter 9   Company Profiles

9.1    Competitive dashboard, 2021

9.2    Gilead Sciences, Inc

9.2.1    Business overview

9.2.2    Financial data

9.2.3    Product landscape

9.2.4    Strategic outlook

9.2.5    SWOT analysis

9.3    Johnson & Johnson

9.3.1    Business overview

9.3.2    Financial data

9.3.3    Product landscape

9.3.4    Strategic outlook

9.3.5    SWOT analysis

9.4    GlaxoSmithKline

9.4.1    Business overview

9.4.2    Financial data

9.4.3    Product landscape

9.4.4    Strategic outlook

9.4.5    SWOT analysis

9.5    AbbVie, Inc

9.5.1    Business overview

9.5.2    Financial data

9.5.3    Product landscape

9.5.4    Strategic outlook

9.5.5    SWOT analysis

9.6    Merck & Co.,

9.6.1    Business overview

9.6.2    Financial data

9.6.3    Product landscape

9.6.4    Strategic outlook

9.6.5    SWOT analysis

9.7    Bristol Myers Squibb

9.7.1    Business overview

9.7.2    Financial data

9.7.3    Product landscape

9.7.4    Strategic outlook

9.7.5    SWOT analysis

9.8    Aurobindo Pharma Limited

9.8.1    Business overview

9.8.2    Financial data

9.8.3    Product landscape

9.8.4    Strategic outlook

9.8.5    SWOT analysis

9.9    Sun Pharmaceutical Industries Ltd

9.9.1    Business overview

9.9.2    Financial data

9.9.3    Product landscape

9.9.4    Strategic outlook

9.9.5    SWOT analysis

9.10    Cipla, Inc.

9.10.1    Business overview

9.10.2    Financial data

9.10.3    Product landscape

9.10.4    Strategic outlook

9.10.5    SWOT analysis

9.11    Mylan N.V.

9.11.1    Business overview

9.11.2    Financial data

9.11.3    Product landscape

9.11.4    Strategic outlook

9.11.5    SWOT analysis
 

Data Tables

TABLE 1    Antiviral drugs market, 2017 - 2021 (USD Million)

TABLE 2    Antiviral drugs market, 2022 - 2028 (USD Million)

TABLE 3    Antiviral drugs market, by drug class, 2017 - 2021 (USD Million)

TABLE 4    Antiviral drugs market, by drug class, 2022 - 2028 (USD Million)

TABLE 5    Antiviral drugs market, by indication, 2017 - 2021 (USD Million)

TABLE 6    Antiviral drugs market, by indication, 2022 - 2028 (USD Million)

TABLE 7    Antiviral drugs market, by type, 2017 - 2021 (USD Million)

TABLE 8    Antiviral drugs market, by type, 2022 - 2028 (USD Million)

TABLE 9    Antiviral drugs market, by age group, 2017 - 2021 (USD Million)

TABLE 10    Antiviral drugs market, by age group, 2022 - 2028 (USD Million)

TABLE 11    Antiviral drugs market, by region, 2017 - 2021 (USD Million)

TABLE 12    Antiviral drugs market, by region, 2022 - 2028 (USD Million)

TABLE 13    Industry impact forces

TABLE 14    DNA polymerase inhibitors market size, by region, 2017 - 2021 (USD Million)

TABLE 15    DNA polymerase inhibitors market size, by region, 2022 - 2028 (USD Million)

TABLE 16    Reverse transcriptase inhibitors market size, by region, 2017 - 2021 (USD Million)

TABLE 17    Reverse transcriptase inhibitors market size, by region, 2022 - 2028 (USD Million)

TABLE 18    Protease inhibitors market size, by region, 2017 - 2021 (USD Million)

TABLE 19    Protease inhibitors market size, by region, 2022 - 2028 (USD Million)

TABLE 20    Neuraminidase inhibitors market size, by region, 2017 - 2021 (USD Million)

TABLE 21    Neuraminidase inhibitors market size, by region, 2022 - 2028 (USD Million)

TABLE 22    Others market size, by region, 2017 - 2021 (USD Million)

TABLE 23    Others market size, by region, 2022 - 2028 (USD Million)

TABLE 24    Influenza market size, by region, 2017 - 2021 (USD Million)

TABLE 25    Influenza market size, by region, 2022 - 2028 (USD Million)

TABLE 26    HIV AIDS market size, by region, 2017 - 2021 (USD Million)

TABLE 27    HIV AIDS market size, by region, 2022 - 2028 (USD Million)

TABLE 28    Hepatitis market size, by region, 2017 - 2021 (USD Million)

TABLE 29    Hepatitis market size, by region, 2022 - 2028 (USD Million)

TABLE 30    Herpes simplex virus market size, by region, 2017 - 2021 (USD Million)

TABLE 31    Herpes simplex virus market size, by region, 2022 - 2028 (USD Million)

TABLE 32    Coronavirus infection market size, by region, 2017 - 2021 (USD Million)

TABLE 33    Coronavirus infection market size, by region, 2022 - 2028 (USD Million)

TABLE 34    Others market size, by region, 2017 - 2021 (USD Million)

TABLE 35    Others market size, by region, 2022 - 2028 (USD Million)

TABLE 36    Branded market size, by region, 2017 - 2021 (USD Million)

TABLE 37    Branded market size, by region, 2022 - 2028 (USD Million)

TABLE 38    Generic market size, by region, 2017 - 2021 (USD Million)

TABLE 39    Generic market size, by region, 2022 - 2028 (USD Million)

TABLE 40    Adult market size, by region, 2017 - 2021 (USD Million)

TABLE 41    Adult market size, by region, 2022 - 2028 (USD Million)

TABLE 42    Pediatric market size, by region, 2017 - 2021 (USD Million)

TABLE 43    Pediatric market size, by region, 2022 - 2028 (USD Million)

TABLE 44    Geriatric market size, by region, 2017 - 2021 (USD Million)

TABLE 45    Geriatric market size, by region, 2022 - 2028 (USD Million)

TABLE 46    North America market size, by country, 2017 - 2021 (USD Million)

TABLE 47    North America market size, by country, 2022 - 2028 (USD Million)

TABLE 48    North America market size, by drug class, 2017 - 2021 (USD Million)

TABLE 49    North America market size, by drug class, 2022 - 2028 (USD Million)

TABLE 50    North America market size, by indication, 2017 - 2021 (USD Million)

TABLE 51    North America market size, by indication, 2022 - 2028 (USD Million)

TABLE 52    North America market size, by type, 2017 - 2021 (USD Million)

TABLE 53    North America market size, by type, 2022 - 2028 (USD Million)

TABLE 54    North America market size, by age group, 2017 - 2021 (USD Million)

TABLE 55    North America market size, by age group, 2022 - 2028 (USD Million)

TABLE 56    U.S. market size, by drug class, 2017 - 2021 (USD Million)

TABLE 57    U.S. market size, by drug class, 2022 - 2028 (USD Million)

TABLE 58    U.S. market size, by indication, 2017 - 2021 (USD Million)

TABLE 59    U.S. market size, by indication, 2022 - 2028 (USD Million)

TABLE 60    U.S. market size, by type, 2017 - 2021 (USD Million)

TABLE 61    U.S. market size, by type, 2022 - 2028 (USD Million)

TABLE 62    U.S. market size, by age group, 2017 - 2021 (USD Million)

TABLE 63    U.S. market size, by age group, 2022 - 2028 (USD Million)

TABLE 64    Canada market size, by drug class, 2017 - 2021 (USD Million)

TABLE 65    Canada market size, by drug class, 2022 - 2028 (USD Million)

TABLE 66    Canada market size, by indication, 2017 - 2021 (USD Million)

TABLE 67    Canada market size, by indication, 2022 - 2028 (USD Million)

TABLE 68    Canada market size, by type, 2017 - 2021 (USD Million)

TABLE 69    Canada market size, by type, 2022 - 2028 (USD Million)

TABLE 70    Canada market size, by age group, 2017 - 2021 (USD Million)

TABLE 71    Canada market size, by age group, 2022 - 2028 (USD Million)

TABLE 72    Europe market size, by country, 2017 - 2021 (USD Million)

TABLE 73    Europe market size, by country, 2022 - 2028 (USD Million)

TABLE 74    Europe market size, by drug class, 2017 - 2021 (USD Million)

TABLE 75    Europe market size, by drug class, 2022 - 2028 (USD Million)

TABLE 76    Europe market size, by indication, 2017 - 2021 (USD Million)

TABLE 77    Europe market size, by indication, 2022 - 2028 (USD Million)

TABLE 78    Europe market size, by type, 2017 - 2021 (USD Million)

TABLE 79    Europe market size, by type, 2022 - 2028 (USD Million)

TABLE 80    Europe market size, by age group, 2017 - 2021 (USD Million)

TABLE 81    Europe market size, by age group, 2022 - 2028 (USD Million)

TABLE 82    Germany market size, by drug class, 2017 - 2021 (USD Million)

TABLE 83    Germany market size, by drug class, 2022 - 2028 (USD Million)

TABLE 84    Germany market size, by indication, 2017 - 2021 (USD Million)

TABLE 85    Germany market size, by indication, 2022 - 2028 (USD Million)

TABLE 86    Germany market size, by type, 2017 - 2021 (USD Million)

TABLE 87    Germany market size, by type, 2022 - 2028 (USD Million)

TABLE 88    Germany market size, by age group, 2017 - 2021 (USD Million)

TABLE 89    Germany market size, by age group, 2022 - 2028 (USD Million)

TABLE 90    UK market size, by drug class, 2017 - 2021 (USD Million)

TABLE 91    UK market size, by drug class, 2022 - 2028 (USD Million)

TABLE 92    UK market size, by indication, 2017 - 2021 (USD Million)

TABLE 93    UK market size, by indication, 2022 - 2028 (USD Million)

TABLE 94    UK market size, by type, 2017 - 2021 (USD Million)

TABLE 95    UK market size, by type, 2022 - 2028 (USD Million)

TABLE 96    UK market size, by age group, 2017 - 2021 (USD Million)

TABLE 97    UK market size, by age group, 2022 - 2028 (USD Million)

TABLE 98    France market size, by drug class, 2017 - 2021 (USD Million)

TABLE 99    France market size, by drug class, 2022 - 2028 (USD Million)

TABLE 100    France market size, by indication, 2017 - 2021 (USD Million)

TABLE 101    France market size, by indication, 2022 - 2028 (USD Million)

TABLE 102    France market size, by type, 2017 - 2021 (USD Million)

TABLE 103    France market size, by type, 2022 - 2028 (USD Million)

TABLE 104    France market size, by age group, 2017 - 2021 (USD Million)

TABLE 105    France market size, by age group, 2022 - 2028 (USD Million)

TABLE 106    Italy market size, by drug class, 2017 - 2021 (USD Million)

TABLE 107    Italy market size, by drug class, 2022 - 2028 (USD Million)

TABLE 108    Italy market size, by indication, 2017 - 2021 (USD Million)

TABLE 109    Italy market size, by indication, 2022 - 2028 (USD Million)

TABLE 110    Italy market size, by type, 2017 - 2021 (USD Million)

TABLE 111    Italy market size, by type, 2022 - 2028 (USD Million)

TABLE 112    Italy market size, by age group, 2017 - 2021 (USD Million)

TABLE 113    Italy market size, by age group, 2022 - 2028 (USD Million)

TABLE 114    Spain market size, by drug class, 2017 - 2021 (USD Million)

TABLE 115    Spain market size, by drug class, 2022 - 2028 (USD Million)

TABLE 116    Spain market size, by indication, 2017 - 2021 (USD Million)

TABLE 117    Spain market size, by indication, 2022 - 2028 (USD Million)

TABLE 118    Spain market size, by type, 2017 - 2021 (USD Million)

TABLE 119    Spain market size, by type, 2022 - 2028 (USD Million)

TABLE 120    Spain market size, by age group, 2017 - 2021 (USD Million)

TABLE 121    Spain market size, by age group, 2022 - 2028 (USD Million)

TABLE 122    Russia market size, by drug class, 2017 - 2021 (USD Million)

TABLE 123    Russia market size, by drug class, 2022 - 2028 (USD Million)

TABLE 124    Russia market size, by indication, 2017 - 2021 (USD Million)

TABLE 125    Russia market size, by indication, 2022 - 2028 (USD Million)

TABLE 126    Russia market size, by type, 2017 - 2021 (USD Million)

TABLE 127    Russia market size, by type, 2022 - 2028 (USD Million)

TABLE 128    Russia market size, by age group, 2017 - 2021 (USD Million)

TABLE 129    Russia market size, by age group, 2022 - 2028 (USD Million)

TABLE 130    Poland market size, by drug class, 2017 - 2021 (USD Million)

TABLE 131    Poland market size, by drug class, 2022 - 2028 (USD Million)

TABLE 132    Poland market size, by indication, 2017 - 2021 (USD Million)

TABLE 133    Poland market size, by indication, 2022 - 2028 (USD Million)

TABLE 134    Poland market size, by type, 2017 - 2021 (USD Million)

TABLE 135    Poland market size, by type, 2022 - 2028 (USD Million)

TABLE 136    Poland market size, by age group, 2017 - 2021 (USD Million)

TABLE 137    Poland market size, by age group, 2022 - 2028 (USD Million)

TABLE 138    Switzerland market size, by drug class, 2017 - 2021 (USD Million)

TABLE 139    Switzerland market size, by drug class, 2022 - 2028 (USD Million)

TABLE 140    Switzerland market size, by indication, 2017 - 2021 (USD Million)

TABLE 141    Switzerland market size, by indication, 2022 - 2028 (USD Million)

TABLE 142    Switzerland market size, by type, 2017 - 2021 (USD Million)

TABLE 143    Switzerland market size, by type, 2022 - 2028 (USD Million)

TABLE 144    Switzerland market size, by age group, 2017 - 2021 (USD Million)

TABLE 145    Switzerland market size, by age group, 2022 - 2028 (USD Million)

TABLE 146    Netherlands market size, by drug class, 2017 - 2021 (USD Million)

TABLE 147    Netherlands market size, by drug class, 2022 - 2028 (USD Million)

TABLE 148    Netherlands market size, by indication, 2017 - 2021 (USD Million)

TABLE 149    Netherlands market size, by indication, 2022 - 2028 (USD Million)

TABLE 150    Netherlands market size, by type, 2017 - 2021 (USD Million)

TABLE 151    Netherlands market size, by type, 2022 - 2028 (USD Million)

TABLE 152    Netherlands market size, by age group, 2017 - 2021 (USD Million)

TABLE 153    Netherlands market size, by age group, 2022 - 2028 (USD Million)

TABLE 154    Sweden market size, by drug class, 2017 - 2021 (USD Million)

TABLE 155    Sweden market size, by drug class, 2022 - 2028 (USD Million)

TABLE 156    Sweden market size, by indication, 2017 - 2021 (USD Million)

TABLE 157    Sweden market size, by indication, 2022 - 2028 (USD Million)

TABLE 158    Sweden market size, by type, 2017 - 2021 (USD Million)

TABLE 159    Sweden market size, by type, 2022 - 2028 (USD Million)

TABLE 160    Sweden market size, by age group, 2017 - 2021 (USD Million)

TABLE 161    Sweden market size, by age group, 2022 - 2028 (USD Million)

TABLE 162    Asia Pacific market size, by country, 2017 - 2021 (USD Million)

TABLE 163    Asia Pacific market size, by country, 2022 - 2028 (USD Million)

TABLE 164    Asia Pacific market size, by drug class, 2017 - 2021 (USD Million)

TABLE 165    Asia Pacific market size, by drug class, 2022 - 2028 (USD Million)

TABLE 166    Asia Pacific market size, by indication, 2017 - 2021 (USD Million)

TABLE 167    Asia Pacific market size, by indication, 2022 - 2028 (USD Million)

TABLE 168    Asia Pacific market size, by type, 2017 - 2021 (USD Million)

TABLE 169    Asia Pacific market size, by type, 2022 - 2028 (USD Million)

TABLE 170    Asia Pacific market size, by age group, 2017 - 2021 (USD Million)

TABLE 171    Asia Pacific market size, by age group, 2022 - 2028 (USD Million)

TABLE 172    Japan market size, by drug class, 2017 - 2021 (USD Million)

TABLE 173    Japan market size, by drug class, 2022 - 2028 (USD Million)

TABLE 174    Japan market size, by indication, 2017 - 2021 (USD Million)

TABLE 175    Japan market size, by indication, 2022 - 2028 (USD Million)

TABLE 176    Japan market size, by type, 2017 - 2021 (USD Million)

TABLE 177    Japan market size, by type, 2022 - 2028 (USD Million)

TABLE 178    Japan market size, by age group, 2017 - 2021 (USD Million)

TABLE 179    Japan market size, by age group, 2022 - 2028 (USD Million)

TABLE 180    China market size, by drug class, 2017 - 2021 (USD Million)

TABLE 181    China market size, by drug class, 2022 - 2028 (USD Million)

TABLE 182    China market size, by indication, 2017 - 2021 (USD Million)

TABLE 183    China market size, by indication, 2022 - 2028 (USD Million)

TABLE 184    China market size, by type, 2017 - 2021 (USD Million)

TABLE 185    China market size, by type, 2022 - 2028 (USD Million)

TABLE 186    China market size, by age group, 2017 - 2021 (USD Million)

TABLE 187    China market size, by age group, 2022 - 2028 (USD Million)

TABLE 188    India market size, by drug class, 2017 - 2021 (USD Million)

TABLE 189    India market size, by drug class, 2022 - 2028 (USD Million)

TABLE 190    India market size, by indication, 2017 - 2021 (USD Million)

TABLE 191    India market size, by indication, 2022 - 2028 (USD Million)

TABLE 192    India market size, by type, 2017 - 2021 (USD Million)

TABLE 193    India market size, by type, 2022 - 2028 (USD Million)

TABLE 194    India market size, by age group, 2017 - 2021 (USD Million)

TABLE 195    India market size, by age group, 2022 - 2028 (USD Million)

TABLE 196    Australia market size, by drug class, 2017 - 2021 (USD Million)

TABLE 197    Australia market size, by drug class, 2022 - 2028 (USD Million)

TABLE 198    Australia market size, by indication, 2017 - 2021 (USD Million)

TABLE 199    Australia market size, by indication, 2022 - 2028 (USD Million)

TABLE 200    Australia market size, by type, 2017 - 2021 (USD Million)

TABLE 201    Australia market size, by type, 2022 - 2028 (USD Million)

TABLE 202    Australia market size, by age group, 2017 - 2021 (USD Million)

TABLE 203    Australia market size, by age group, 2022 - 2028 (USD Million)

TABLE 204    South Korea market size, by drug class, 2017 - 2021 (USD Million)

TABLE 205    South Korea market size, by drug class, 2022 - 2028 (USD Million)

TABLE 206    South Korea market size, by indication, 2017 - 2021 (USD Million)

TABLE 207    South Korea market size, by indication, 2022 - 2028 (USD Million)

TABLE 208    South Korea market size, by type, 2017 - 2021 (USD Million)

TABLE 209    South Korea market size, by type, 2022 - 2028 (USD Million)

TABLE 210    South Korea market size, by age group, 2017 - 2021 (USD Million)

TABLE 211    South Korea market size, by age group, 2022 - 2028 (USD Million)

TABLE 212    Singapore market size, by drug class, 2017 - 2021 (USD Million)

TABLE 213    Singapore market size, by drug class, 2022 - 2028 (USD Million)

TABLE 214    Singapore market size, by indication, 2017 - 2021 (USD Million)

TABLE 215    Singapore market size, by indication, 2022 - 2028 (USD Million)

TABLE 216    Singapore market size, by type, 2017 - 2021 (USD Million)

TABLE 217    Singapore market size, by type, 2022 - 2028 (USD Million)

TABLE 218    Singapore market size, by age group, 2017 - 2021 (USD Million)

TABLE 219    Singapore market size, by age group, 2022 - 2028 (USD Million)

TABLE 220    Indonesia market size, by drug class, 2017 - 2021 (USD Million)

TABLE 221    Indonesia market size, by drug class, 2022 - 2028 (USD Million)

TABLE 222    Indonesia market size, by indication, 2017 - 2021 (USD Million)

TABLE 223    Indonesia market size, by indication, 2022 - 2028 (USD Million)

TABLE 224    Indonesia market size, by type, 2017 - 2021 (USD Million)

TABLE 225    Indonesia market size, by type, 2022 - 2028 (USD Million)

TABLE 226    Indonesia market size, by age group, 2017 - 2021 (USD Million)

TABLE 227    Indonesia market size, by age group, 2022 - 2028 (USD Million)

TABLE 228    Thailand market size, by drug class, 2017 - 2021 (USD Million)

TABLE 229    Thailand market size, by drug class, 2022 - 2028 (USD Million)

TABLE 230    Thailand market size, by indication, 2017 - 2021 (USD Million)

TABLE 231    Thailand market size, by indication, 2022 - 2028 (USD Million)

TABLE 232    Thailand market size, by type, 2017 - 2021 (USD Million)

TABLE 233    Thailand market size, by type, 2022 - 2028 (USD Million)

TABLE 234    Thailand market size, by age group, 2017 - 2021 (USD Million)

TABLE 235    Thailand market size, by age group, 2022 - 2028 (USD Million)

TABLE 236    Malaysia market size, by drug class, 2017 - 2021 (USD Million)

TABLE 237    Malaysia market size, by drug class, 2022 - 2028 (USD Million)

TABLE 238    Malaysia market size, by indication, 2017 - 2021 (USD Million)

TABLE 239    Malaysia market size, by indication, 2022 - 2028 (USD Million)

TABLE 240    Malaysia market size, by type, 2017 - 2021 (USD Million)

TABLE 241    Malaysia market size, by type, 2022 - 2028 (USD Million)

TABLE 242    Malaysia market size, by age group, 2017 - 2021 (USD Million)

TABLE 243    Malaysia market size, by age group, 2022 - 2028 (USD Million)

TABLE 244    Philippines market size, by drug class, 2017 - 2021 (USD Million)

TABLE 245    Philippines market size, by drug class, 2022 - 2028 (USD Million)

TABLE 246    Philippines market size, by indication, 2017 - 2021 (USD Million)

TABLE 247    Philippines market size, by indication, 2022 - 2028 (USD Million)

TABLE 248    Philippines market size, by type, 2017 - 2021 (USD Million)

TABLE 249    Philippines market size, by type, 2022 - 2028 (USD Million)

TABLE 250    Philippines market size, by age group, 2017 - 2021 (USD Million)

TABLE 251    Philippines market size, by age group, 2022 - 2028 (USD Million)

TABLE 252    Latin America market size, by country, 2017 - 2021 (USD Million)

TABLE 253    Latin America market size, by country, 2022 - 2028 (USD Million)

TABLE 254    Latin America market size, by drug class, 2017 - 2021 (USD Million)

TABLE 255    Latin America market size, by drug class, 2022 - 2028 (USD Million)

TABLE 256    Latin America market size, by indication, 2017 - 2021 (USD Million)

TABLE 257    Latin America market size, by indication, 2022 - 2028 (USD Million)

TABLE 258    Latin America market size, by type, 2017 - 2021 (USD Million)

TABLE 259    Latin America market size, by type, 2022 - 2028 (USD Million)

TABLE 260    Latin America market size, by age group, 2017 - 2021 (USD Million)

TABLE 261    Latin America market size, by age group, 2022 - 2028 (USD Million)

TABLE 262    Brazil market size, by drug class, 2017 - 2021 (USD Million)

TABLE 263    Brazil market size, by drug class, 2022 - 2028 (USD Million)

TABLE 264    Brazil market size, by indication, 2017 - 2021 (USD Million)

TABLE 265    Brazil market size, by indication, 2022 - 2028 (USD Million)

TABLE 266    Brazil market size, by type, 2017 - 2021 (USD Million)

TABLE 267    Brazil market size, by type, 2022 - 2028 (USD Million)

TABLE 268    Brazil market size, by age group, 2017 - 2021 (USD Million)

TABLE 269    Brazil market size, by age group, 2022 - 2028 (USD Million)

TABLE 270    Mexico market size, by drug class, 2017 - 2021 (USD Million)

TABLE 271    Mexico market size, by drug class, 2022 - 2028 (USD Million)

TABLE 272    Mexico market size, by indication, 2017 - 2021 (USD Million)

TABLE 273    Mexico market size, by indication, 2022 - 2028 (USD Million)

TABLE 274    Mexico market size, by type, 2017 - 2021 (USD Million)

TABLE 275    Mexico market size, by type, 2022 - 2028 (USD Million)

TABLE 276    Mexico market size, by age group, 2017 - 2021 (USD Million)

TABLE 277    Mexico market size, by age group, 2022 - 2028 (USD Million)

TABLE 278    Argentina market size, by drug class, 2017 - 2021 (USD Million)

TABLE 279    Argentina market size, by drug class, 2022 - 2028 (USD Million)

TABLE 280    Argentina market size, by indication, 2017 - 2021 (USD Million)

TABLE 281    Argentina market size, by indication, 2022 - 2028 (USD Million)

TABLE 282    Argentina market size, by type, 2017 - 2021 (USD Million)

TABLE 283    Argentina market size, by type, 2022 - 2028 (USD Million)

TABLE 284    Argentina market size, by age group, 2017 - 2021 (USD Million)

TABLE 285    Argentina market size, by age group, 2022 - 2028 (USD Million)

TABLE 286    MEA market size, by country, 2017 - 2021 (USD Million)

TABLE 287    MEA market size, by country, 2022 - 2028 (USD Million)

TABLE 288    MEA market size, by drug class, 2017 - 2021 (USD Million)

TABLE 289    MEA market size, by drug class, 2022 - 2028 (USD Million)

TABLE 290    MEA market size, by indication, 2017 - 2021 (USD Million)

TABLE 291    MEA market size, by indication, 2022 - 2028 (USD Million)

TABLE 292    MEA market size, by type, 2017 - 2021 (USD Million)

TABLE 293    MEA market size, by type, 2022 - 2028 (USD Million)

TABLE 294    MEA market size, by age group, 2017 - 2021 (USD Million)

TABLE 295    MEA market size, by age group, 2022 - 2028 (USD Million)

TABLE 296    South Africa market size, by drug class, 2017 - 2021 (USD Million)

TABLE 297    South Africa market size, by drug class, 2022 - 2028 (USD Million)

TABLE 298    South Africa market size, by indication, 2017 - 2021 (USD Million)

TABLE 299    South Africa market size, by indication, 2022 - 2028 (USD Million)

TABLE 300    South Africa market size, by type, 2017 - 2021 (USD Million)

TABLE 301    South Africa market size, by type, 2022 - 2028 (USD Million)

TABLE 302    South Africa market size, by age group, 2017 - 2021 (USD Million)

TABLE 303    South Africa market size, by age group, 2022 - 2028 (USD Million)

TABLE 304    Saudi Arabia market size, by drug class, 2017 - 2021 (USD Million)

TABLE 305    Saudi Arabia market size, by drug class, 2022 - 2028 (USD Million)

TABLE 306    Saudi Arabia market size, by indication, 2017 - 2021 (USD Million)

TABLE 307    Saudi Arabia market size, by indication, 2022 - 2028 (USD Million)

TABLE 308    Saudi Arabia market size, by type, 2017 - 2021 (USD Million)

TABLE 309    Saudi Arabia market size, by type, 2022 - 2028 (USD Million)

TABLE 310    Saudi Arabia market size, by age group, 2017 - 2021 (USD Million)

TABLE 311    Saudi Arabia market size, by age group, 2022 - 2028 (USD Million)

TABLE 312    UAE market size, by drug class, 2017 - 2021 (USD Million)

TABLE 313    UAE market size, by drug class, 2022 - 2028 (USD Million)

TABLE 314    UAE market size, by indication, 2017 - 2021 (USD Million)

TABLE 315    UAE market size, by indication, 2022 - 2028 (USD Million)

TABLE 316    UAE market size, by type, 2017 - 2021 (USD Million)

TABLE 317    UAE market size, by type, 2022 - 2028 (USD Million)

TABLE 318    UAE market size, by age group, 2017 - 2021 (USD Million)

TABLE 319    UAE market size, by age group, 2022 - 2028 (USD Million)
 

Charts & Figures

FIG. 1    Antiviral drugs industry 360º synopsis, 2017 - 2028

FIG. 2    Industry segmentation

FIG. 3    Antiviral drugs industry landscape, 2017 - 2028 (USD Million)

FIG. 4    Growth potential analysis, by drug class

FIG. 5    Growth potential analysis, by indication

FIG. 6    Growth potential analysis, by type

FIG. 7    Growth potential analysis, by age group

FIG. 8    Porter’s analysis

FIG. 9    PESTEL analysis

FIG. 10    Key segment trends, by drug class

FIG. 11    Key segment trends, by indication

FIG. 12    Key segment trends, by type

FIG. 13    Key segment trends, by age group

FIG. 14    Key regional trends

FIG. 15    Competitive dashboard, 2021

   

Authors: Sumant Ugalmugle, Rupali Swain

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2021
  • Companies covered: 10
  • Tables & Figures: 334
  • Countries covered: 28
  • Pages: 195

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount